Bavarian Nordic A/S (BVNRY)
11.08
+0.24
(+2.26%)
USD |
OTCM |
Oct 05, 16:00
Bavarian Nordic Max Drawdown (5Y) : 74.23% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 74.23% |
| August 31, 2026 | 74.23% |
| July 31, 2026 | 74.23% |
| June 30, 2026 | 74.23% |
| May 31, 2026 | 74.23% |
| April 30, 2026 | 74.23% |
| March 31, 2026 | 74.23% |
| February 28, 2026 | 74.23% |
| January 31, 2026 | 74.23% |
| December 31, 2025 | 74.95% |
| November 30, 2025 | 78.22% |
| October 31, 2025 | 78.22% |
| September 30, 2025 | 78.22% |
| August 31, 2025 | 78.22% |
| July 31, 2025 | 78.22% |
| June 30, 2025 | 79.60% |
| May 31, 2025 | 79.60% |
| April 30, 2025 | 82.74% |
| March 31, 2025 | 88.04% |
| February 28, 2025 | 88.04% |
| January 31, 2025 | 88.04% |
| December 31, 2024 | 88.04% |
| November 30, 2024 | 88.04% |
| October 31, 2024 | 88.04% |
| September 30, 2024 | 88.04% |
| Date | Value |
|---|---|
| August 31, 2024 | 88.04% |
| July 31, 2024 | 88.04% |
| June 30, 2024 | 88.04% |
| May 31, 2024 | 88.04% |
| April 30, 2024 | 88.04% |
| March 31, 2024 | 88.04% |
| February 29, 2024 | 88.04% |
| January 31, 2024 | 88.04% |
| December 31, 2023 | 88.04% |
| November 30, 2023 | 88.04% |
| October 31, 2023 | 88.04% |
| September 30, 2023 | 88.04% |
| August 31, 2023 | 88.04% |
| July 31, 2023 | 88.04% |
| June 30, 2023 | 88.04% |
| May 31, 2023 | 88.04% |
| April 30, 2023 | 88.04% |
| March 31, 2023 | 88.04% |
| February 28, 2023 | 88.04% |
| January 31, 2023 | 88.04% |
| December 31, 2022 | 88.04% |
| November 30, 2022 | 88.04% |
| October 31, 2022 | 88.04% |
| September 30, 2022 | 88.04% |
| August 31, 2022 | 88.04% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Evaxion AS | 99.79% |
| Genmab A/S | 63.10% |
| Ascendis Pharma A/S | 61.72% |
| Zealand Pharma A/S | 74.12% |
| Agenus, Inc. | 98.84% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -25.29 |
| Beta (5Y) | 1.251 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 57.27% |
| Historical Sharpe Ratio (5Y) | -0.223 |
| Historical Sortino (5Y) | -0.4664 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 22.25% |